Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience.

Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience.

Item
http://www.wikidata.org/entity/Q33984071
Mechanisms involved in the development of chemotherapy-induced neuropathyAAPT Diagnostic Criteria for Chronic Cancer Pain ConditionsCorneal Confocal Microscopy Detects Small Fibre Neuropathy in Patients with Upper Gastrointestinal Cancer and Nerve Regeneration in Chemotherapy Induced Peripheral NeuropathyEvaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment.Chemotherapy-Related Neurotoxicity.Vitamin E does not decrease the incidence of chemotherapy-induced peripheral neuropathy: a meta-analysis.Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.Mechanisms of Neurotoxic Symptoms as a Result of Breast Cancer and Its Treatment: Considerations on the Contribution of Stress, Inflammation, and Cellular BioenergeticsLong-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall riskTaxane-Induced Peripheral Neurotoxicity.Peripheral neuropathy induced by microtubule-targeted chemotherapies: insights into acute injury and long-term recovery.Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy.Jekyll and Hyde of chemotherapy treatment: Method for patient-specific dosing of chemotherapy medications.Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy.Selective Blockade of the Sigma 1 Receptor Has Beneficial Effects on Both Acute and Chronic Oxaliplatin-Induced Peripheral Neuropathy.Serum micronutrients and prealbumin during development and recovery of chemotherapy-induced peripheral neuropathy.Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study.
P2860

Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience.

Item
http://www.wikidata.org/entity/Q33984071
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Chemotherapy dose reduction du ...... s: a single-center experience.
@ast
Chemotherapy dose reduction du ...... s: a single-center experience.
@en
type
label
Chemotherapy dose reduction du ...... s: a single-center experience.
@ast
Chemotherapy dose reduction du ...... s: a single-center experience.
@en
prefLabel
Chemotherapy dose reduction du ...... s: a single-center experience.
@ast
Chemotherapy dose reduction du ...... s: a single-center experience.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Chemotherapy dose reduction du ...... gs: a single-center experience
@en
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932